BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5781330)

  • 1. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
    Linati E
    Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
    Bianchi PG; Saccabusi E
    Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
    Borellini D; Milvio C
    Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
    Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
    Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
    Uzeta Mejia S
    Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
    Bellomo A; Strobbia R; Manzoni A
    Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
    Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
    Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
    Gambini G; Grisler R
    Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of "Sinulene" in gastroduddenal ulcer and in gastroduodenitis. Clinical experience].
    Siciliani M
    Minerva Chir; 1968 Aug; 23(15):810-4. PubMed ID: 5686717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Signs of tolerability in man, clinical pharmacology and activity of a new non-anticholinergic product active in gastroduodenitis and gastroduodenal ulcer (Milid)].
    Casone A; Borellini D; Jezzi B
    Minerva Med; 1967 Oct; 58(86):3699-704. PubMed ID: 6061064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid].
    Abbona C; Gatto PL; Bezante GC
    Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aluminium glycyrrhetate in the therapy of gastroduodenal peptic ulcer and of other gastroduodenal diseases].
    Fontana G; Faggioli F
    Minerva Med; 1969 Feb; 60(17):745-60. PubMed ID: 5776059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
    Sampietro R
    Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
    Mainoli S; Milvio C; Borellini D
    Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled clinical evaluation of the therapeutic value of antacid-antiulcer preparation].
    Lattanzi A; De Liperi E
    Minerva Med; 1967 Oct; 58(87):3736-43. PubMed ID: 6075229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of the therapeutic use of a sulfated glycoprotein].
    Bayeli PF; Cartocci L
    Minerva Gastroenterol; 1973; 19(3):164-74. PubMed ID: 4766770
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of gastritis and gastro-duodenal ulcers with drugs with predominantly spasmolytic and vasodilating action].
    Cascone A; Ferrari F
    Minerva Gastroenterol; 1969; 15(2):60-77. PubMed ID: 4389365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trials in several centers of aluminium glycyrrhetate in the therapy of ulcer disease].
    Bassi M; Botti G; Cacciari C; Cavazzuti F; Fontana G; Gambigliani Zoccoli A; Jori GP; Ponari O; Preziosi P; Visioli O
    Minerva Med; 1969 Feb; 60(17):721-37. PubMed ID: 5776058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and experimental data on some secretory functional aspects of the stomach in patients with gastrointestinal diseases treated with a gel of aluminum or magnesium hydroxide in a colloidal suspension ("Maalox")].
    Abbona C; Gatto PL; Bezante GC
    Minerva Gastroenterol; 1969; 15(2):86-93. PubMed ID: 5815483
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proglumide (milide) in gastroduodenal therapeutics].
    Geoffroy H; el-Haddad A; Coudoux P
    Sem Hop Ther; 1974 Mar; 50(3):207-16. PubMed ID: 4612709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.